Perrigo Company plc Restructuring Charges
Perrigo Company plc (PRGO) reported Restructuring Charges of $14.40 million for the 3-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2026-08-05
- Perrigo Company plc restructuring charges for the quarter ending 2026-06-27 was $14.40M, a 65.52% increase year-over-year.
- Perrigo Company plc restructuring charges for the quarter ending 2026-03-28 was $75.10M, a 155.44% increase year-over-year.
- Perrigo Company plc restructuring charges for the quarter ending 2025-12-31 was $13.00M, a 8.33% increase year-over-year.
- Perrigo Company plc restructuring charges for the quarter ending 2025-09-27 was $20.80M, a 23.81% increase year-over-year.
- Perrigo Company plc restructuring charges for fiscal 2025 was $71.90M, a 34.70% decline from fiscal 2024.
- Perrigo Company plc restructuring charges for fiscal 2024 was $110.10M, a 160.90% increase from fiscal 2023.
- Perrigo Company plc restructuring charges for fiscal 2023 was $42.20M, a 0.71% decline from fiscal 2022.
- Perrigo Company plc restructuring charges for fiscal 2022 was $42.50M, a 151.48% increase from fiscal 2021.
| Period end | Restructuring Charges 3 month | Restructuring Charges 3 month as first filed | Restructuring Charges 6 month | Restructuring Charges 6 month as first filed | Restructuring Charges 9 month | Restructuring Charges 9 month as first filed | Restructuring Charges 12 month | Restructuring Charges 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-27 | $14.40M 10-Q · filed 2026-08-05 | $89.50M 10-Q · filed 2026-08-05 | $102.50M derived: sum of 3 quarters · filed 2026-08-05 | $123.30M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-28 | $75.10M 10-Q · filed 2026-05-06 | $88.10M derived: sum of 2 quarters · filed 2026-05-06 | $108.90M derived: sum of 3 quarters · filed 2026-05-06 | $117.60M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $13.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $33.80M derived: sum of 2 quarters · filed 2026-02-26 | $42.50M derived: sum of 3 quarters · filed 2026-08-05 | $71.90M 10-K · filed 2026-02-26 | ||||
| 2025-09-27 | $20.80M 10-Q · filed 2025-11-05 | $29.50M derived: sum of 2 quarters · filed 2026-08-05 | $58.90M 10-Q · filed 2025-11-05 | $70.90M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-28 | $8.70M 10-Q · filed 2026-08-05 | $38.10M 10-Q · filed 2026-08-05 | $50.10M derived: sum of 3 quarters · filed 2026-08-05 | $66.90M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-29 | $29.40M 10-Q · filed 2026-05-06 | $41.40M derived: sum of 2 quarters · filed 2026-05-06 | $58.20M derived: sum of 3 quarters · filed 2026-05-06 | $95.10M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $28.80M derived: sum of 2 quarters · filed 2026-02-26 | $65.70M derived: sum of 3 quarters · filed 2026-02-26 | $110.10M 10-K · filed 2026-02-26 | ||||
| 2024-09-28 | $16.80M 10-Q · filed 2025-11-05 | $53.70M derived: sum of 2 quarters · filed 2025-11-05 | $98.10M 10-Q · filed 2025-11-05 | $114.50M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-29 | $36.90M 10-Q · filed 2025-08-06 | $81.30M 10-Q · filed 2025-08-06 | $97.70M derived: sum of 3 quarters · filed 2026-02-26 | $113.20M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-30 | $44.30M 10-Q · filed 2025-05-07 | $60.80M derived: sum of 2 quarters · filed 2026-02-26 | $76.30M derived: sum of 3 quarters · filed 2026-02-26 | $83.00M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $16.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $32.00M derived: sum of 2 quarters · filed 2026-02-26 | $38.70M derived: sum of 3 quarters · filed 2026-02-26 | $42.20M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $15.50M 10-Q · filed 2024-11-06 | $22.20M derived: sum of 2 quarters · filed 2024-11-06 | $25.70M 10-Q · filed 2024-11-06 | $35.90M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-07-01 | $6.70M 10-Q · filed 2024-08-02 | $10.20M 10-Q · filed 2024-08-02 | $20.40M derived: sum of 3 quarters · filed 2025-02-28 | $39.50M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-04-01 | $3.40M 10-Q · filed 2024-05-07 | $13.70M derived: sum of 2 quarters · filed 2025-02-28 | $32.80M derived: sum of 3 quarters · filed 2025-02-28 | $42.30M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $10.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $29.40M derived: sum of 2 quarters · filed 2025-02-28 | $38.90M derived: sum of 3 quarters · filed 2025-02-28 | $42.50M 10-K · filed 2025-02-28 | ||||
| 2022-10-01 | $19.10M 10-Q · filed 2023-11-07 | $28.60M derived: sum of 2 quarters · filed 2023-11-07 | $32.20M 10-Q · filed 2023-11-07 | $37.30M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-07-02 | $9.50M 10-Q · filed 2023-08-08 | $13.10M 10-Q · filed 2023-08-08 | $18.20M derived: sum of 3 quarters · filed 2024-02-27 | $19.20M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-04-02 | $3.60M 10-Q · filed 2023-05-09 | $8.70M derived: sum of 2 quarters · filed 2024-02-27 | $9.70M derived: sum of 3 quarters · filed 2024-02-27 | $18.70M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2021-12-31 | $5.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $6.10M derived: sum of 2 quarters · filed 2024-02-27 | $15.10M derived: sum of 3 quarters · filed 2024-02-27 | $16.90M 10-K · filed 2024-02-27 | ||||
| 2021-10-02 | $1.00M 10-Q · filed 2022-11-08 | $10.00M derived: sum of 2 quarters · filed 2022-11-08 | $11.80M 10-Q · filed 2022-11-08 | $13.40M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-07-03 | $9.00M 10-Q · filed 2022-08-09 | $10.70M 10-Q · filed 2022-08-09 | $12.40M derived: sum of 3 quarters · filed 2023-02-28 | $13.20M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-04-03 | $1.70M 10-Q · filed 2022-05-11 | $3.40M derived: sum of 2 quarters · filed 2023-02-28 | $4.20M derived: sum of 3 quarters · filed 2023-02-28 | $4.90M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $2.50M derived: sum of 2 quarters · filed 2023-02-28 | $3.20M derived: sum of 3 quarters · filed 2023-02-28 | $3.20M 10-K · filed 2023-02-28 | $3.50M 10-K · filed 2021-03-01 | |||
| 2020-09-26 | $800.00K 10-Q · filed 2021-11-12 | $1.50M derived: sum of 2 quarters · filed 2021-11-12 | $1.50M 10-Q · filed 2021-11-12 | $1.90M 10-Q · filed 2020-11-05 | $700.00K derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-06-27 | $700.00K 10-Q · filed 2021-08-11 | $1.10M 10-Q · filed 2020-08-05 | $700.00K 10-Q · filed 2021-08-11 | $1.10M 10-Q · filed 2020-08-05 | -$100.00K derived: sum of 3 quarters · filed 2022-03-01 | $5.10M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-28 | $0.00 10-Q · filed 2021-05-12 | -$800.00K derived: sum of 2 quarters · filed 2022-03-01 | $4.40M derived: sum of 3 quarters · filed 2022-03-01 | $16.60M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | -$800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $4.40M derived: sum of 2 quarters · filed 2022-03-01 | $16.60M derived: sum of 3 quarters · filed 2022-03-01 | $25.90M 10-K · filed 2022-03-01 | $26.30M 10-K · filed 2020-02-27 | |||
| 2019-09-28 | $5.20M 10-Q · filed 2020-11-05 | $17.40M derived: sum of 2 quarters · filed 2021-03-01 | $26.70M 10-Q · filed 2020-11-05 | $24.50M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-29 | $12.20M 10-K · filed 2021-03-01 | $21.50M 10-Q · filed 2020-08-05 | $19.30M derived: sum of 3 quarters · filed 2021-03-01 | $37.30M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-30 | $9.30M 10-Q · filed 2020-05-05 | $7.10M derived: sum of 2 quarters · filed 2021-03-01 | $25.10M derived: sum of 3 quarters · filed 2021-03-01 | $28.80M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | -$2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $15.80M derived: sum of 2 quarters · filed 2021-03-01 | $19.50M derived: sum of 3 quarters · filed 2021-03-01 | $21.00M 10-K · filed 2021-03-01 | ||||
| 2018-09-29 | $18.00M 10-K · filed 2020-02-27 | $21.70M derived: sum of 2 quarters · filed 2020-02-27 | $23.20M 10-Q · filed 2019-11-06 | $29.50M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | $3.70M 10-Q · filed 2019-08-08 | $5.20M 10-Q · filed 2019-08-08 | $11.50M derived: sum of 3 quarters · filed 2020-02-27 | $15.30M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | $1.50M 10-Q · filed 2019-05-09 | $7.80M derived: sum of 2 quarters · filed 2020-02-27 | $11.60M derived: sum of 3 quarters · filed 2020-02-27 | $23.70M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $6.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $10.10M derived: sum of 2 quarters · filed 2020-02-27 | $22.20M derived: sum of 3 quarters · filed 2020-02-27 | $61.00M 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | $3.80M 10-Q · filed 2018-11-08 | $15.90M derived: sum of 2 quarters · filed 2018-11-08 | $54.70M 10-Q · filed 2018-11-08 | $67.70M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-07-01 | $12.10M 10-Q · filed 2018-08-09 | $50.80M 10-Q · filed 2018-08-09 | $63.90M derived: sum of 3 quarters · filed 2019-02-27 | $70.50M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-04-01 | $38.70M 10-K · filed 2019-02-27 | $51.80M derived: sum of 2 quarters · filed 2019-02-27 | $58.40M derived: sum of 3 quarters · filed 2019-02-27 | $64.20M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | $13.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $19.70M derived: sum of 2 quarters · filed 2019-02-27 | $25.50M derived: sum of 3 quarters · filed 2019-02-27 | $31.00M 10-K · filed 2019-02-27 | ||||
| 2016-10-01 | $6.60M 10-Q · filed 2017-11-09 | $12.40M derived: sum of 2 quarters · filed 2017-11-09 | $17.90M 10-Q · filed 2017-11-09 | $42.50M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-07-02 | $5.80M 10-Q · filed 2017-08-10 | $11.30M 10-Q · filed 2017-08-10 | $35.90M derived: sum of 3 quarters · filed 2018-03-01 | $38.10M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-04-02 | $5.40M 10-Q · filed 2017-05-30 | $30.10M derived: sum of 2 quarters · filed 2018-03-01 | $32.30M derived: sum of 3 quarters · filed 2018-03-01 | $32.20M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2015-12-31 | $24.70M 10-K · filed 2018-03-01 | $26.90M 10-K · filed 2018-03-01 | $26.80M derived: sum of 3 quarters · filed 2018-03-01 | $27.90M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2015-09-26 | $2.20M 10-Q/A · filed 2017-05-23 | $2.10M derived: sum of 2 quarters · filed 2017-05-23 | $3.10M 10-Q/A · filed 2017-05-23 | $5.60M derived: sum of 4 quarters · filed 2017-05-23 | ||||
| 2015-06-27 | -$100.00K 10-Q/A · filed 2017-05-22 | $1.00M 10-Q/A · filed 2017-05-22 | $3.40M derived: sum of 3 quarters · filed 2017-05-22 | $5.10M 10-K · filed 2018-03-01 | ||||
| 2015-03-28 | $1.10M 10-Q/A · filed 2017-05-22 | $3.50M derived: sum of 2 quarters · filed 2017-05-22 | $5.30M 10-Q · filed 2015-04-29 | $15.70M derived: sum of 4 quarters · filed 2017-05-22 | ||||
| 2014-12-27 | $2.40M 10-K · filed 2015-08-13 | $4.20M 10-K · filed 2018-03-01 | $14.60M derived: sum of 3 quarters · filed 2016-02-25 | $34.10M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-09-27 | $1.70M 10-Q · filed 2015-11-02 | $12.20M derived: sum of 2 quarters · filed 2016-02-25 | $31.70M derived: sum of 3 quarters · filed 2016-02-25 | $46.60M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-06-28 | $10.50M 10-KT · filed 2016-02-25 | $30.00M derived: sum of 2 quarters · filed 2016-02-25 | $44.90M derived: sum of 3 quarters · filed 2016-02-25 | $47.00M 10-K · filed 2017-05-22 | ||||
| 2014-03-29 | $19.50M 10-KT · filed 2016-02-25 | $34.40M derived: sum of 2 quarters · filed 2016-02-25 | $36.50M 10-Q · filed 2015-04-29 | $39.40M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-12-28 | $14.90M 10-KT · filed 2016-02-25 | $17.00M 10-Q · filed 2015-02-05 | $19.90M derived: sum of 3 quarters · filed 2016-02-25 | $19.90M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-09-28 | $2.10M 8-K · filed 2014-11-20 | $5.00M derived: sum of 2 quarters · filed 2016-02-25 | $5.00M derived: sum of 3 quarters · filed 2016-02-25 | $5.00M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-06-29 | $2.90M derived: 10-KT 12 month − 10-Q 9 month · filed 2016-02-25 | $2.90M derived: sum of 2 quarters · filed 2016-02-25 | $2.90M derived: sum of 3 quarters · filed 2016-02-25 | $2.90M 10-KT · filed 2016-02-25 | ||||
| 2013-03-30 | $0.00 10-Q · filed 2014-05-07 | $0.00 derived: sum of 2 quarters · filed 2014-05-07 | $0.00 10-Q · filed 2014-05-07 | |||||
| 2012-12-29 | $0.00 10-Q · filed 2014-02-06 | $0.00 10-Q · filed 2014-02-06 | ||||||
| 2012-06-30 | $8.80M 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |